Literature DB >> 17395091

Research & market strategy: how choice of drug discovery approach can affect market position.

Frank Sams-Dodd1.   

Abstract

In principal, drug discovery approaches can be grouped into target- and function-based, with the respective aims of developing either a target-selective drug or a drug that produces a specific biological effect irrespective of its mode of action. Most analyses of drug discovery approaches focus on productivity, whereas the strategic implications of the choice of drug discovery approach on market position and ability to maintain market exclusivity are rarely considered. However, a comparison of approaches from the perspective of market position indicates that the functional approach is superior for the development of novel, innovative treatments.

Entities:  

Mesh:

Year:  2007        PMID: 17395091     DOI: 10.1016/j.drudis.2007.02.014

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  4 in total

1.  Entry time effects and follow-on drug competition.

Authors:  Luiz Flavio Andrade; Catherine Sermet; Sylvain Pichetti
Journal:  Eur J Health Econ       Date:  2014-12-12

2.  C. elegans as an in vivo model system for the phenotypic drug discovery for treating paraquat poisoning.

Authors:  Peng Ji; Hongyuan Li; Yushan Jin; Yinghua Peng; Lihui Zhao; Xiaohui Wang
Journal:  PeerJ       Date:  2022-02-01       Impact factor: 2.984

3.  A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model.

Authors:  Lenka Munoz; Hantamalala Ralay Ranaivo; Saktimayee M Roy; Wenhui Hu; Jeffrey M Craft; Laurie K McNamara; Laura Wing Chico; Linda J Van Eldik; D Martin Watterson
Journal:  J Neuroinflammation       Date:  2007-09-04       Impact factor: 8.322

Review 4.  Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery.

Authors:  Douglas B Kell; Royston Goodacre
Journal:  Drug Discov Today       Date:  2013-07-26       Impact factor: 7.851

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.